A snapshot of gene therapy in Latin America

AUTOR(ES)

Linden, Rafael, Matte, Ursula

FONTE

Genet. Mol. Biol.

DATA DE PUBLICAÇÃO

2014

RESUMO

Gene therapy attempts the insertion and expression of exogenous genetic material in cells for therapeutic purposes. Conceived in the 1960s, gene therapy reached its first clinical trial at the end of the 1980s and by December 2013 around 600 genuine open clinical trials of gene therapy were registered at NIH Clinical Trials Database. Here, we summarize the current efforts towards the development of gene therapy in Latin America. Our survey shows that the number of scientists involved in the development of gene therapy and DNA vaccines in Latin America is still very low. Higher levels of investment in this technology are necessary to boost the advancement of innovation and intellectual property in this field in a way that would ease both the social and financial burden of various medical conditions in Latin America.

Documentos Relacionados

• Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
• Aesculapius in Latin America
• BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES
• Zoonotic tuberculosis in Latin America.
• POPULATION DILEMMA IN LATIN AMERICA